国际医疗器械设计与制造技术展览会

Dedicated to design & manufacturing for medical device

September 24-26,2025 | SWEECC H1&H2

EN | 中文
   

首页 > Forum on R&D and Innovation of Implantable Interventional Products under Centralized Procurement

Forum on R&D and Innovation of Implantable Interventional Products under Centralized Procurement

Introduction

Agenda

Speaker

Sponsor/Package

Registration

Transportation

Forum on R&D and Innovation of Implantable Interventional Products under Centralized Procurement 

organizers: Medtec China

Introduction

Conference Background:

  • The safety and reliability of medical devices is essential for mankind all over the world. Regulatory authorities in various countries have become more and stricterto manage the risk of medical devices throughout the life cycle. Post-marketing supervision is also an important task for major enterprises. According to the requirements of new laws and regulations in China, the “14th Five-Year Plan” puts forward the requirement of setting registrants as the monitoring subject for the first time, and implements the subject responsibility of enterprises from the division of tasks and working mechanism.
  • On October 22, 2021, the Provisions for Self-inspection of Medical Device Registration issued by NMPAis one of the supporting documents for the newly revised Regulations for the Supervision and Administration of Medical Devices. The Provisions allow medical device enterprises to choose between self-inspection or entrusted inspection, which is conducive to accelerating the speed of medical device registration inspection, improving the level of testing ability, compacting the subject responsibility of registrants, stimulating the vitality of industrial innovation and further promoting the high-quality development of the medical device industry.
  • The implementation of UDI will pose a profound impact on the quality and safety supervision of all links in the whole life cycle of medical devices. Now, Class III medical devices have been fully promoted and implemented in China. Since May 26, this year, the scope of implementation of UDI in EU regions will be extended to Class IIa and IIb medical devices and Class III-reusable medical devices and Class D in vitro diagnostic reagents. Currently, the implementation of UDI for implantable devices and Class III devices has been completed in the European Union.

 

Who Should Attend?

  • Medical Device Manufacturer: Head of Regulatory, Quality, Compliance, Medical, R & D and Project/Enterprise
  • Medical Device Regulatory Consulting, Research and Service Companies
  • Medical Device Supervision Authorities and Scientific Research Institutions

*Conference agenda updates according to speaker confirming.

.

Agenda

>> Medtec lnnovation Forum 2023 Conference and Event Agenda

Speaker

Yunfeng Chou,  Deputy Secretary-General,  Committee for Surgical Implants China Association of Medical Device Industry

Anny Fan, Deputy Secretary General, China Surgical Implant Professional Committee

Zikai Hua, Vice Dean, School of Mechatronic Engineering and Automation

Wenbo Jiang, Executive Vice Director, Medical 3D Printing Innovation Research Center,Shanghai Jiaotong University

Vickery Tu, Director of Information Solution Development Center, Guan Cheng, Guan Cheng Information Technology Co., Ltd.

Aiguo Wang, GM, Jiangsu Yisong Medical Technology Co., Ltd.

Eric Liu, General Manager, Suzhou Zhengfeng Micro-Nano Technology Co.,Ltd

Sponsor/Package

 

>> Sponsor Package

 

Registration

>> Registration

Transportation
 

Speech & Cooperation

Carina Li

T:+86 10 6562 3308

E:[email protected]

Sponsor & Paid Conference

Julia Zhu

+86-21 6157 3922

E:[email protected]

Media & Free Conference

Carina Li

T:+86 10 6562 3307

E:[email protected]

X